Literature DB >> 18940034

Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial.

Lone Petersen1, Anne Thorup, Johan Øqhlenschlaeger, Torben Øqstergaard Christensen, Pia Jeppesen, Gertrud Krarup, Per Jørrgensen, Erik Lykke Mortensen, Merete Nordentoft.   

Abstract

OBJECTIVE: To examine the frequency and predictors of good outcome for patients with first-episode schizophrenia spectrum disorder (SSD).
METHOD: We conducted a 2-year follow-up of a cohort of patients (n = 547) with first-episode SSD. We evaluated the patients on demographic variables, diagnosis, duration of untreated psychosis (DUP), premorbid functioning, psychotic and negative symptoms, substance abuse, adherence to medication, and service use. ORs were calculated with logistic regression analyses.
RESULTS: A total of 369 patients (67%) participated in the follow-up interview. After 2 years, 36% remitted and 17% were considered fully recovered. Full recovery was associated with shorter DUP, better premorbid adjustment, fewer negative symptoms at baseline, no substance abuse at baseline, and adherence to medication and OPUS treatment.
CONCLUSIONS: Several predictive factors were identified, and focus should be on potentially malleable predictors of outcome, for example, reducing DUP and paying special attention to patients who are unlikely to achieve good outcome, for example, patients with a substance abuse problem and poor premorbid adjustment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940034     DOI: 10.1177/070674370805301005

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  18 in total

1.  Evaluation of a multi-element treatment center for early psychosis in the United States.

Authors:  Sarah R Uzenoff; David L Penn; Karen A Graham; Sylvia Saade; Barbara B Smith; Diana O Perkins
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-01-26       Impact factor: 4.328

Review 2.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

3.  Predictors and Prevalence of Recovery and Remission for Consumers Discharged from Mental Hospitals in a Chinese Society.

Authors:  Daniel K W Young; Petrus Y N Ng; Jiayan Pan
Journal:  Psychiatr Q       Date:  2017-12

4.  Remission and recovery during the first outpatient year of the early course of schizophrenia.

Authors:  Joseph Ventura; Kenneth L Subotnik; Lisa H Guzik; Gerhard S Hellemann; Michael J Gitlin; Rachel C Wood; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2011-07-18       Impact factor: 4.939

5.  Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.

Authors:  Philippe Conus; Sue Cotton; Benno G Schimmelmann; Patrick D McGorry; Martin Lambert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-05-05       Impact factor: 4.328

6.  Où en sommes-nous? An Overview of Successes and Challenges after 30 Years of Early Intervention Services for Psychosis in Quebec: Où en sommes-nous? Un aperçu des réussites et des problèmes après 30 ans de services d'intervention précoce pour la psychose au Québec.

Authors:  Bastian Bertulies-Esposito; Marie Nolin; Srividya N Iyer; Ashok Malla; Phil Tibbo; Nicola Otter; Manuela Ferrari; Amal Abdel-Baki
Journal:  Can J Psychiatry       Date:  2020-01-08       Impact factor: 4.356

7.  The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.

Authors:  Moogeh Baharnoori; Cali Bartholomeusz; Aurelie A Boucher; Lisa Buchy; Christopher Chaddock; Bonga Chiliza; Melanie Föcking; Alex Fornito; Juan A Gallego; Hiroaki Hori; Gisele Huf; Gul A Jabbar; Shi Hyun Kang; Yousri El Kissi; Jessica Merchán-Naranjo; Gemma Modinos; Nashaat A M Abdel-Fadeel; Anna-Karin Neubeck; Hsiao Piau Ng; Gabriela Novak; Olasunmbo O Owolabi; Diana P Prata; Naren P Rao; Igor Riecansky; Darryl C Smith; Renan P Souza; Renate Thienel; Hanan D Trotman; Hiroyuki Uchida; Kristen A Woodberry; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2010-10-08       Impact factor: 4.939

8.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

9.  Early Intervention for Psychosis in Canada: What Is the State of Affairs?

Authors:  Marie Nolin; Ashok Malla; Phil Tibbo; Ross Norman; Amal Abdel-Baki
Journal:  Can J Psychiatry       Date:  2016-03       Impact factor: 4.356

Review 10.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.